TPWA
ABBV icon

Twin Peaks Wealth Advisors’s AbbVie ABBV Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$802K Buy
3,187
+109
+4% +$23.5K 0.18% 94
2026
Q1 		$669K Buy
3,078
+94
+3% +$20.9K 0.17% 91
2025
Q4 		$666K Buy
2,984
+126
+4% +$28.7K 0.19% 87
2025
Q3 		$662K Sell
2,858
-33
-1% -$6.72K 0.23% 80
2025
Q2 		$574K Buy
2,891
+323
+13% +$60K 0.19% 84
2025
Q1 		$454K Sell
2,568
-24
-0.9% -$4.67K 0.21% 90
2024
Q4 		$461K Buy
2,592
+52
+2% +$9.56K 0.19% 86
2024
Q3 		$502K Buy
2,540
+266
+12% +$49.6K 0.23% 72
2024
Q2 		$390K Sell
2,274
-70
-3% -$11.6K 0.19% 86
2024
Q1 		$427K Buy
2,344
+16
+0.7% +$2.76K 0.24% 76
2023
Q4 		$361K Buy
+2,328
New +$339K 0.23% 88

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Twin Peaks Wealth Advisors's ABBV Position: Q2 2026 in Review

Twin Peaks Wealth Advisors increased its AbbVie (ABBV) stake by 3.5% in Q2 2026, buying an estimated $23.5K and bringing the position to 3,187 shares worth $802K. The position accounts for 0.18% of the portfolio, ranked #94.

Twin Peaks Wealth Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Twin Peaks Wealth Advisors held 3,187 shares of AbbVie worth $802K as of Q2 2026.
  • Twin Peaks Wealth Advisors bought 109 AbbVie shares in Q2 2026, an estimated $23.5K.
  • AbbVie made up 0.18% of Twin Peaks Wealth Advisors's portfolio in Q2 2026, its #94 holding.
  • Twin Peaks Wealth Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.